Both in Pharmaceuticals
TransCode Therapeutics vs BeyondSpring
Over the past year RNAZ returned −88.8% and BYSI returned −68.4%; their daily moves had a correlation of 0.07.
RNAZ −88.8% BYSI −68.4%Growth of $1, one year, split-adjusted
| Metric | RNAZ | BYSI |
|---|---|---|
| Price | $1.70 | $0.5592 |
| Market cap | $28.8M | $23.0M |
| Today | −5.56% | −3.90% |
| 1 month | −1.2% | −21.1% |
| 6 months | −80.7% | −67.7% |
| Year to date | −75.1% | −65.7% |
| 1 year | — | −66.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.7M | $6.5M |
| Dividend yield | — | — |
| Volatility (60d) | 91.4% | 154.3% |
| Short % of float | 6.3% | 7.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).